Morristown Medical Center: Leading Edge Research in CAR-T and TIL therapy - Takeaways - MDSpire

Morristown Medical Center: Leading Edge Research in CAR-T and TIL therapy

Morristown Medical Center now offers patients access to innovative clinical trials for immunotherapies including the use of Chimeric Antigen Receptor T Cells (CAR-T) and Tumor Infiltrating Lymphocytes (TIL).

  • By

  • March 11, 2024

  • 2 min

Share

  • 1

    Morristown Medical Center offers innovative clinical trials for CAR-T and TIL therapies through a partnership with TGen.

  • 2

    The Beckman Advanced Cellular Therapy Unit has been established to enhance patient care and outcomes for those receiving immunotherapy.

  • 3

    This unit features advanced hemodynamic monitoring technology and is staffed by highly trained nurses.

  • 4

    The Atlantic Cellular Therapy program aims to provide safe access to cutting-edge clinical care for cancer patients.

  • 5

    Morristown Medical Center is recognized for its leadership in advanced treatments for blood cancers like leukemia and lymphoma.

Original Source(s)

Morristown Medical Center: Leading Edge Research in CAR-T and TIL therapy

  • by

  • March 11, 2024

Related Content

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

FOXA2 in cancer: from fundamental biology to clinical translation